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A Ab bs st tr ra ac ct t A 100 kb region on 9p21.3 harbors two major disease susceptibility loci: one for type 2 diabetes (T2D) and one for coronary heart disease (CHD). The single nucleotide polymorphisms (SNPs) associated with these two diseases in Europeans reside on two adjacent haplotype blocks with independent effects on disease. To help delimit the regions that likely harbor the disease-causing variants in populations of non-European origin, we studied the haplotype diversity and allelic history of the 9p21.3 region using 938 unrelated individuals from 51 populations (Human Genome Diversity Panel). We used SNP data from Illumina's 650Y SNP arrays supplemented with five additional SNPs within the region of interest. Haplotype frequencies were analyzed with the EM algorithm implemented in PLINK. For the T2D locus, the TT risk haplotype of SNPs rs10811661 and rs10757283 was present at similar frequencies in all global populations, while a shared 6-SNP haplotype that carries the protective C allele of rs10811661 was found at a frequency of 2.9% in Africans and 41.3% in East Asians and was associated with low haplotype diversity. For the CHD locus, all populations shared a core risk haplotype spanning >17.5 kb, which shows dramatic increase in frequency between African (11.5%) and Middle Eastern (63.7%) populations. Interestingly, two SNPs (rs2891168 and rs10757278) tagging this CHD risk haplotype are most strongly associated with CHD disease status according to independent clinical fine-mapping studies. The large variation in linkage disequilibrium patterns identified between the populations demonstrates the importance of allelic background data when selecting SNPs for replication in global populations. Intriguingly, the protective allele for T2D and the risk allele for CHD show an increase in frequency in non-Africans compared to Africans, implying different population histories for these two adjacent disease loci.
F Fi in nd di in ng gs s
A 100 kb region on chromosome 9p21.3 has been recently identified as harboring susceptibility variants to both coronary heart disease (CHD)/myocardial infarction [1] [2] [3] [4] [5] and to type 2 diabetes (T2D) [6, 7] in study populations of European origin. The associated variants reside on two adjacent haplotype blocks, as defined using HapMap data from 30 trios of Northern and Western European ancestry (CEU) collected by the Centre d'Etude du Polymorphisme Humain (CEPH) [8] . The effects of the variants are independent: the T2D risk variant does not confer increased risk of CHD, and vice versa [9, 10] . The variants associated with CHD also contribute to the risk of other disease phenotypes, such as abdominal aortic and intracranial aneurysms [10] and ischemic stroke [11] . The extensive linkage disequilibrium (LD) seen in this genomic region in the CEU HapMap population is diminished in the other HapMap populations of African, Chinese and Japanese ancestry, both for pair-wise LD levels as well as size of the haplotype blocks. In addition, the disease-associated variants are located in a genomic region of unknown function. These two issues contribute to the challenge of identifying the possible causative variants, and studying their effects in populations of non-European ancestry.
To help delimit the regions that likely harbor the diseasecausing variants in populations of non-European origin, we studied the haplotype diversity and allelic history of the 9p21.3 region using existing genotype data from 938 unrelated individuals from 51 populations, from Sub-Saharan Africa, North Africa, Europe, the Middle East, South/Central Asia, East Asia, Oceania and the Americas (the Human Genome Diversity Panel (HGDP-CEPH) [12] ). Descriptions of genome-wide single nucleotide polymorphism (SNP) variation across these populations have recently been published by two independent groups, using Illumina's HumanHap550 BeadChip in 29 populations [13] and HumanHap650Y BeadChip in 51 populations [14] . Here we present an analysis of the 650Y SNP data [14] , supplemented with five additional SNPs: rs11790231, rs10965227, rs7045889 and rs10811661 typed using Sequenom iPLEX chemistry (Sequenom, San Diego, CA, USA) and rs1333049 typed using KASPar chemistry (Kbioscience, Hoddesdon, Herts, UK) [15] . The additional SNPs were selected to include disease-associated SNPs and haplotype-tagging SNPs that were not present on the 650Y chip. Genotype quality controls included eight duplicates of a CEPH sample and eight water controls in every 384-well plate. Genotype clusters were manually reviewed and genotyping success rate for each SNP was >98.9%. The genotype data included the variants associated with T2D (rs10811661 and rs10757283), as well as eight variants associated with CHD or found in high LD (r 2 > 0.9) with associated variants across a 44 kb region (rs10116277, rs1537370, rs10738607, rs4977574, rs944797, rs2383207, rs1537375 and rs1333049) in the HapMap CEU population. Haplotype frequencies were analyzed with the EM algorithm implemented in PLINK [16] , which estimates the frequencies of probabilistically inferred sets of haplotypes within a population-based sample set. Haplotype structure was visualized with Haploview [17] . The analysis was performed for each geographic region separately, including in the analysis all individuals from the various populations in that geographic region. Due to the small number of unrelated individuals studied here and the uncertainty of phasing, we omit region-specific haplotypes with frequencies <5%.
Our analyses show that the T2D and CHD loci have different allelic histories, which is in agreement with their independent effects on disease. The haplotype structure of the critical region containing the CHD-and T2D-associated SNPs in the HGDP European sample is shown in Figure 1 , and for comparison the same region is shown in the HGDP African sample (Additional data file 1). For the T2D locus, the T allele of rs10811661 was found to be associated with disease risk [6] , while a larger meta-analysis identified haplotype TT of rs10811661 and rs10757283 as most strongly associated with disease [7] . The TT risk haplotype is present in similar frequencies in all global populations, while a shared 6-SNP haplotype that carries the protective C allele of rs10811661 is found at a frequency of 2.9% in Africans and 41.3% in East Asians and is associated with low haplotype diversity ( Table 1 ). This frequency difference between populations and lack of haplotype diversity of the protective allele is reminiscent of the TCF7L2 T2D locus, in which the protective allele is found at a frequency of 10 to 31% in Africans but at 95% in East Asians [15, 18] . Such large allele frequency differences and lack of haplotype diversity are indications of the past action of positive natural selection [19] . However, the degree of population differentiation for rs10811661 is not unusual compared to random SNPs in the genome (Fst = 0.126 (P = 0.224) across the 51 HGDP populations) [15] , suggesting a neutrally selected region, while the protective allele of rs7901695 at the TCF7L2 locus was likely driven to high frequency in East Asians (global Fst = 0.213 (P = 0.08) across the 51 HGDP populations) by positive selection [18] .
The risk allele frequencies of four of the CHD-associated SNPs are shown in Figure 2 . Although these SNPs show highly similar allele frequencies and are in almost perfect LD in European populations (r 2 > 0.9), they show dramatic differences in allele frequencies across other populations, most notably in African populations. In order to decipher which of these risk alleles might be the true causative variant (or in high LD with it) and thus may be suitable for testing in non-European populations, we studied the haplotype diversity across the different geographic regions for eight highly correlated CHD-associated SNPs (r 2 > 0.9 in CEU HapMap population; Table 2 ). All populations appear to share a core risk haplotype as a part of the longer risk haplotype identified in Europeans. This risk haplotype (GGGC, for SNPs rs4977574, rs944797, rs2383207, rs1537375) spans >17.5 kb, and is tagged by the risk allele G of SNP rs4977574. The G allele of rs4977574 is also the best tag SNP for the longer risk haplotype (>44.1 kb) that is most common in all populations. All the other CHD-associated risk alleles were also found on other haplotypes in non-European populations.
The risk allele of rs4977574 shows a dramatic change in frequency between African and Middle Eastern populations (Figure 2) , and tags the only 8-SNP haplotype of African origin that becomes common in European populations (Table 2) . Interestingly, two comprehensive fine-mapping rs7045889  rs10757282  rs10116277  rs1333040  rs15373707  rs10738607  rs4977574  rs944797  rs1537375  rs10965243  rs10965227  rs1333049  rs2383208  rs1333050  rs10757283  rs10811659  rs10811661   rs10757278  rs2891168  ANRIL (5' 3') 5 kb
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T Ta ab bl le e 1 1 T Th he e f fr re eq qu ue en nc ci ie es s o of f e es st ti im ma at te ed d 6 6--S SN NP P h ha ap pl lo ot ty yp pe es s † † f fo or r t th he e 9 9p p2 21 1. .3 3 T T2 2D D l lo oc cu us s i in n s se ev ve en n d di if ff fe er re en nt t g ge eo og gr ra ap ph hi ic c r re eg gi io on ns s The TT haplotype of SNPs rs10811661 and rs10757283 is the T2D risk haplotype and is in bold-face and marked with an asterisk, while the protective haplotype (GAAGCT) is in bold-face and italicized. † Population-specific haplotypes <5% frequent were omitted. NF, haplotype not found in given geographic region. Risk allele frequency studies of this region in case-control samples have identified SNPs in the same haplotype block as rs4977574 (rs2891168 and rs10757278, shown in Figure 1 ) as most strongly associated with disease [1, 9] . These three SNPs (rs4977574, rs2891168, and rs10757278) are highly correlated with each other in all four HapMap populations and are the most appropriate for further analyses in non-Europeans. The 44 kb LD region harbors the ANRIL (antisense noncoding RNA in the INK4 locus) gene, which codes for a large antisense non-coding RNA, and was found to be expressed in tissues involved in atherosclerosis [9] . The three CHD risk haplotype tagging SNPs are located in regions of regulatory potential, as defined from alignments of several mammalian sequences [20, 21] , and thus may be representing the actual functional domains associated with disease risk.
A handful of replication studies in non-European populations for CHD-related phenotypes have been published to date. Most of these studies make use of populations of East Asian ancestry [22] [23] [24] [25] in which patterns of LD are similar to LD patterns in Europeans. Not surprisingly, these studies confirm previously described associations with disease phenotypes discovered in populations of European ancestry. A replication study in a multi-ethnic sample [26] that included relatively small numbers of cases and controls per ethnic origin confirmed association in Hispanics, but found no association in African Americans, possibly due to the small sample size and the low frequency of the alleles studied. Studies from populations of diverse ancestry are generally lacking. Our results demonstrate the importance of ancestry-specific allelic background when selecting SNPs for replication in global populations, and demonstrate that this approach can complement fine-mapping studies to possibly identify novel putative causative variant/s. Intriguingly, our data imply very different population histories for these two adjacent disease loci, with an increase in the prevalence of the T2D protective allele, most notably in East Asian populations, versus an increase in the prevalence of the CHD risk allele already in Middle Eastern populations. The HGDP SNP data we used here are publicly available and represent a valuable resource for studies of other complex diseases.
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